BIT 3.33% 3.1¢ biotron limited

Ann: Significant Immunological Outcomes in BIT225 HIV-1 Trial, page-24

  1. 10,103 Posts.
    lightbulb Created with Sketch. 656
    Don't underestimate this news IMHO. From my understanding this is the holy grail, eradication from reservoir cells.

    BIT has had some much promise, and it looks like they hit the biggest home run.
 
watchlist Created with Sketch. Add BIT (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.